Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction.

Ken WatanabeTetsu WatanabeYoichiro OtakiTetsuro ShishidoTakayo MuraseTakashi NakamuraShigehiko KatoHarutoshi TamuraSatoshi NishiyamaHiroki TakahashiTakanori ArimotoMasafumi Watanabe

Published in: ESC heart failure (2020)

Elevated plasma XOR activity is significantly associated with adverse clinical outcomes in patients with HFpEF.

Keyphrases

emergency department
metabolic syndrome